Developer docs
API playgroundTry for free, no card

Search company profiles

Teckro

Full company profile

uuid00049ip

Namestring
Teckro
Legal namestring
Teckro Limited
Websiteurl
teckro.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDublin, Ireland
HQ citystring
Dublin
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial platform, clinical site management, digital clinical trials, site engagement software, clinical trial technology
Industry1 code
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code3 codes
  • Computer Systems Design and Related Services5415
  • Other Scientific and Technical Consulting Services541690
  • Computer Systems Design Services541512
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Management Consulting Services8742
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Technology / eClinical Platform
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Teckro operates as a SaaS platform providing clinical trial site performance solutions to pharmaceutical sponsors and biotech companies. The platform is offered to sponsors who then deploy it across their clinical trial sites, generating recurring subscription revenue based on study count, site count, or enterprise-wide agreements.

teckro.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS pricing - custom quote-based
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing is not publicly disclosed; the company uses a demo request and consultation model indicating enterprise B2B sales with customized pricing based on study scope, site count, and service requirements.

teckro.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Teckro provides a cloud-based SaaS platform that connects clinical trial sponsors, Contract Research Organizations (CROs), and research sites through a single, mobile-first interface. The platform centralizes site communications, study information access, protocol queries, and oversight workflows, and is augmented by a dedicated Premium Service offering that embeds Teckro expert teams with sponsor staff. Together, the technology and service help sponsors accelerate study start-up, improve site engagement, and gain real-time visibility into trial performance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 23% higher recruitment rate for engaged sites compared to non-engaged counterparts
+8 more records
Product overview1 text field

Teckro is a cloud-native SaaS clinical trial platform delivering the only data-driven site performance solution. The core platform combines a mobile-first digital experience (available on web, iPad, Android, and iOS) with 360° oversight dashboards and a premium service offering. Key modules include FAQ Copilot (generative AI-powered question answering), Patient Data Return (patient-centric data access), Site Performance Quadrant (predictive site segmentation), Protocol Query Channel (secure expert Q&A), and Targeted Communications (segmented study messaging). The platform also features intelligent search, built-in surveys, oversight dashboards with compliance KPIs, and role-aligned CRA workflows. Sites report a 94% registration rate and 80% of frequent users request Teckro on more studies.

Product and service2 records
1Teckro Platform
CategoryClinical Trial Technology Platform
2Premium Service
Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Biogen and Teckro co-presented at SCOPE Summit 2026 on patient data return, specifically on delivering individual data records to participants at scale. The partnership demonstrates a strategic collaboration on patient-centric clinical trial innovation, with Biogen focusing on strategy and execution for patient data return programs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Teckro

Clinical Trial Technology / eClinical Platformteckro.com

Teckro firmographics

Firmographics
Name
Teckro
Legal name
Teckro Limited
Website
https://teckro.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Teckro industry classification

Industry
Product category
Clinical Trial Technology / eClinical Platform
NAICS
Computer Systems Design and Related Services (5415), Other Scientific and Technical Consulting Services (541690), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical trial platform
  • Clinical site management
  • Digital clinical trials
  • Site engagement software
  • Clinical trial technology

Where Teckro is headquartered

Location

Headquarters

HQ city
Dublin
HQ country
Ireland
HQ region
Europe

Offices2 records

Markets served

Teckro business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Teckro operates as a SaaS platform providing clinical trial site performance solutions to pharmaceutical sponsors and biotech companies. The platform is offered to sponsors who then deploy it across their clinical trial sites, generating recurring subscription revenue based on study count, site count, or enterprise-wide agreements.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS pricing - custom quote-based

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Teckro product offering

Product offering

Core offering

Teckro provides a cloud-based SaaS platform that connects clinical trial sponsors, Contract Research Organizations (CROs), and research sites through a single, mobile-first interface. The platform centralizes site communications, study information access, protocol queries, and oversight workflows, and is augmented by a dedicated Premium Service offering that embeds Teckro expert teams with sponsor staff. Together, the technology and service help sponsors accelerate study start-up, improve site engagement, and gain real-time visibility into trial performance.

Product overview

Teckro is a cloud-native SaaS clinical trial platform delivering the only data-driven site performance solution. The core platform combines a mobile-first digital experience (available on web, iPad, Android, and iOS) with 360° oversight dashboards and a premium service offering. Key modules include FAQ Copilot (generative AI-powered question answering), Patient Data Return (patient-centric data access), Site Performance Quadrant (predictive site segmentation), Protocol Query Channel (secure expert Q&A), and Targeted Communications (segmented study messaging). The platform also features intelligent search, built-in surveys, oversight dashboards with compliance KPIs, and role-aligned CRA workflows. Sites report a 94% registration rate and 80% of frequent users request Teckro on more studies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Teckro Platform
  • Premium Service

Quantifiable outcome

  • 23% higher recruitment rate for engaged sites compared to non-engaged counterparts
  • +8 more outcomes

Companies that use Teckro

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Teckro technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Teckro partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BiogenflagshipStrategic or Co-development Partner · 1 January 2026Biogen and Teckro co-presented at SCOPE Summit 2026 on patient data return, specifically on delivering individual data records to participants at scale. The partnership demonstrates a strategic collaboration on patient-centric clinical trial innovation, with Biogen focusing on strategy and execution for patient data return programs.

Scale indicators17 records

Recent moves6 records

Expansion highlights5 records

Teckro competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Teckro social profiles

Digital presence

Teckro compliance and trust

Trust signal

Compliance4 records

Teckro financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teckro leadership team

Management profile

Number of profiles

Profiles12 records

Teckro funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teckro M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teckro

What does Teckro do?

Teckro provides a cloud-based SaaS platform that connects clinical trial sponsors, Contract Research Organizations (CROs), and research sites through a single, mobile-first interface. The platform centralizes site communications, study information access, protocol queries, and oversight workflows, and is augmented by a dedicated Premium Service offering that embeds Teckro expert teams with sponsor staff. Together, the technology and service help sponsors accelerate study start-up, improve site engagement, and gain real-time visibility into trial performance.

Is Teckro a public or private company?

Teckro is a private company. It is classified as venture growth investor backed and is currently operating.

When was Teckro founded?

Teckro was founded in 2015. It employs 101 to 250 people.

Where is Teckro based?

Teckro is headquartered in Dublin, Ireland, in the Europe region.

How does Teckro make money?

One revenue line is on record: saaS Platform Subscription.

Does Teckro have an API?

No public API is recorded for Teckro.

What industry is Teckro in?

Teckro's product category is Clinical Trial Technology / eClinical Platform. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5415 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
B2B SaaS BlogTeckro Revenue 2025: $14.2M Est. ARR (Bootstrapped)Teckro, a company headquartered in Limerick, is estimated to have achieved $14.2 million in Annual Recurring Revenue (ARR) for 2025 while operating as a bootstrapped business. The company provides a site performance solution for clinical trials that aims to optimize sponsor spending and improve enrollment rates through data-driven oversight.BioXconomyBuilding clinical trial data return from the inside outTeckro has added a Patient Data Return feature to its clinical trials platform, allowing patient-participants to digitally access their trial data and share it with their healthcare providers. The feature aims to improve patient engagement and trial efficiency while ensuring compliance with regulations including GDPR and HIPAA across 78 countries. Early pilot results show participants are already using the portal to access and export their information, with sponsors and trial sites gaining real-time insights into patient engagement.Financial PostClinical ink and Teckro Partner to Enhance Site User EngagementClinical ink, a company specializing in eSource and complex site data collection, announced a partnership with Teckro, a mobile site engagement solutions provider, to improve the clinical trial experience for research staff and investigators. The collaboration combines Clinical ink's Direct Data Capture expertise with Teckro's mobile app, enabling immediate execution of inclusion/exclusion review, eConsent facilitation, and streamlined site-sponsor communication. The companies expect the partnership to deliver benefits including a single native app for all protocols and decentralized access to study experts.GlobeNewswireClinical ink and Teckro Partner to Enhance Site User EngagementClinical ink and Teckro announced a partnership to combine Clinical ink's Direct Data Capture with Teckro's mobile app for clinical trial site engagement. The collaboration aims to streamline eConsent, reduce administrative burden, and provide a single app for all protocols. It is expected to be available globally to site partners.SecSEC FORM DTECKRO, INC. filed a Form D with the U.S. Securities and Exchange Commission to report an exempt securities offering under Rule 506(b). The company disclosed total offering and sales amounts of $24,999,989 USD, with five investors participating in the transaction.Business Wire BlogTeckro Launches Next-Generation Clinical Trial Mobile Platform, Giving Site Staff Faster Answers in Fewer ClicksTeckro announced a next-generation mobile app and the Teckro Powered program to accelerate site adoption of modern trial practices. The app provides answers in fewer clicks, and new studies can be added in half the time. The program is open to any research site.Clinical Trials ArenaHow to increase efficiency and agility in oncology trialsAn opinion piece by Teckro chief medical officer Brendan Buckley argues that oncology trials remain inefficient and non-compliant because they rely on manual, paper-based processes such as printed protocols and email communication. He cites a 10% annual inflation in required procedures and tests, and notes only 8% of US cancer patients are enrolled in trials. Teckro promotes its digital platform, including Teckro Search, Connect, Engage and Survey.LimerickpostTeckro Expands Product Portfolio to Unblock Clinical Research Site StaffClinical trial software provider Teckro, based in Limerick, Ireland, launched Teckro Connect, a mobile application letting research site staff query study experts directly through a secure, regulated communication channel. The company says the tool addresses delays and mistrust in answers, with threads exportable to trial master files and compliant with 21 CFR Part 11. Teckro is used at more than 18,000 active research sites worldwide.Pharmaceutical TechnologyWhy going digital is the right step for the pharma industryTeckro, a clinical trial software provider, advocates for the pharmaceutical industry to transition from paper-based processes to digital platforms to enhance efficiency, safety, and regulatory compliance. The company cites successful completion of over 100 trials without regulatory criticism and highlights how digital solutions became critical during the COVID-19 pandemic for remote monitoring and data security.Clinical Trials ArenaHow paper protocols may be harming your clinical trial’s successIrish software firm Teckro is promoting its digital engagement platform as a solution to the pharmaceutical industry's continued reliance on paper protocols for clinical trials, which contributes to protocol violations and patient safety risks. The platform is currently used by more than 16,700 research sites across six continents, with reported benefits including improved patient recruitment and fewer protocol deviations. The article argues that digitizing protocols would provide instant access to approved versions, support regulatory compliance, and improve efficiency during patient consultations.